Search

everythinglearnresearchcommunity

for

Search:↓

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

Treating acute myeloid leukemia is challenging, especially in older adults, despite some advancements.

Combining ciclosporin and simvastatin can cause severe kidney damage.

LAAM caused developmental toxicity in tolerant rats without causing birth defects.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

Rheumatology clinics should always provide preconception counseling for women on DMARDs.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

The cat improved with treatment but had kidney issues from long-term allopurinol use.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

Elental is a good long-term treatment for Crohn's disease, similar to 6-mercaptopurine but with fewer side effects.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Anti-CD19 therapy may help treat SLE and NMOSD.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.